|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Allergan Inc. (AGN) CEO’s Pay Jumps by Half With $9 Million Stock Award
2/25/2013 8:22:22 AM
Allergan Inc. (AGN) Chief Executive Officer David Pyott’s compensation jumped 51 percent last year after the maker of the Botox wrinkle treatment awarded him $9.39 million in stock, according to a company filing. Pyott, CEO since 1998, made $21.2 million last year, including the stock award, $1.3 million in salary, a $1.65 million cash bonus and $7.01 million in options awards, Irvine, California-based Allergan said in a Securities and Exchange Commission filing today. Pyott, who also is chairman and president, was paid total compensation of $13.9 million in 2011. The company’s board said the award was part of a plan to keep Pyott with the company for at least five more years. Under his tenure, the board said, Allergan’s market value has grown to $33.1 billion from about $2 billion.
|
|
|
|
|
|
|
|
|
|
|